Streetbeat News

Products Services

ABVC

ADIL

NA

Adial Pharmaceuticals (ADIL) shares surged 108% following the publication of a peer-reviewed article on AD04's clinical results and safety. Nano Labs (NA) filed its annual report, showing a 70% increase. ABVC BioPharma (ABVC) announced a global licensing agreement for oncology/hematology products, expecting $55M in licensing income and up to $50M in royalties.

Portfolio Pulse from ryanfaloona@benzinga.com

April 10, 2024 | 12:39 pm

WKHS

Workhorse Group has expanded its dealer network by adding Ziegler Truck Group. This move is aimed at enhancing Workhorse's distribution capabilities and market reach for its electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:38 pm

FEPI

FTXL

MU

PSI

QCOM

SOXQ

Micron Technology, Inc. (MU) and Qualcomm Incorporated (QCOM) have partnered to integrate Micron's automotive-grade memory and storage solutions into Qualcomm's Snapdragon Digital Chassis for AI-powered intelligent vehicle development. This collaboration aims to enhance the performance and safety of next-generation vehicles. MU stock has seen a 93% increase over the past year, while QCOM stock has gained over 41%. Investors can also gain exposure to these stocks through ETFs like FEPI, FTXL, SOXQ, and PSI.

Portfolio Pulse from Nabaparna Bhattacharya

April 10, 2024 | 12:38 pm

KULR

KULR Technology Group, Inc. (NYSE:KULR) has successfully delivered custom-designed KULR ONE battery packs to the U.S. Army, significantly enhancing the efficiency and longevity of Uninterruptible Power Supplies in tactical command settings. This delivery under a multi-year contract represents a major achievement in KULR's commitment to innovation and specialized energy solutions, achieving an 80% improvement in UPS run times for the Army's future command posts.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:36 pm

NXL

Nexalin Technology, under CEO Mark White, has reported significant progress in 2023 and is poised for greater achievements in 2024, focusing on improving mental healthcare outcomes. The company announced positive clinical results for its Gen-2 tACS device in treating mTBI and PTSD among military veterans, and chronic insomnia in adults, with data published in the Journal of Psychiatric Research. Nexalin introduced the HALO™ Clarity and the Virtual Clinic, aiming to enhance treatment accessibility. The company has formed a military and government advisory board, received regulatory approval in Oman, and is pursuing FDA approval in the US. Nexalin's IP portfolio has been strengthened with new patents extending through 2040, covering its core technology and the HALO™ Clarity system.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:36 pm

OST

Ostin Technology Group Co., Ltd. (NASDAQ:OST), a leading supplier of display modules and polarizers, announced the commencement of operations of its US subsidiary, Pintura.Life LLC, in San Francisco. This move is part of its strategy to expand into the North American market with its Pintura products. The company launched a crowdfunding campaign on Indiegogo for Pintura, aiming to introduce it to a broader U.S. and North American audience. The San Francisco presence is seen as a strategic step to leverage local talent and market opportunities in North America.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:35 pm

MRIN

MSFT

Marin Software Inc (NASDAQ:MRIN) shares surged after announcing upgrades to its Microsoft Corp (NASDAQ:MSFT) advertising integration. The enhancements include AI-powered budget optimization and improved conversion metrics, aiming to boost advertising campaign success. This follows a recent approval of a 1-for-6 reverse stock split by Marin stockholders.

Portfolio Pulse from Adam Eckert

April 10, 2024 | 12:34 pm

RKLB

Rocket Lab USA, Inc. (RKLB) has reintegrated a previously flown Electron rocket first stage tank into its production line for reflight, marking a significant step towards making Electron the world's first reusable small orbital launch vehicle. The tank, recovered from the 'Four of a Kind' mission in January 2024, has passed extensive acceptance tests, including tank pressurization, helium leak check, and carbon fiber structural testing. This move is part of Rocket Lab's iterative development process aimed at Electron's reusability, with the recovered stage set to undergo final testing to confirm its suitability for reflight.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:34 pm

DRIO

DarioHealth Corp. (DRIO) announced the publication of two peer-reviewed studies demonstrating the effectiveness of its digital behavioral health interventions. One of the studies, a Randomized Controlled Trial, showed a significant reduction in perceived stress among teenagers using Dario's platform.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:34 pm

MBRX

Moleculin Biotech, Inc. presented data for its anthracycline product, indicating progress in its development. This could impact investor sentiment and the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 12:34 pm